CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical interact focused on oncology, proclaimed that its Phase II Trial evaluating CR011-vcMMAE for the act of patients with unresectable Stage trinity or Stage IV melanoma has met the effectualness criteria for utilization to the 95th make of enrollment. Of the prototypal opus evaluable patients in […]

BALTIMORE — Veterans sweptback from the Irak effort crapper participate rest disturbances as blue as those among habitual insomniacs, researchers said here.

KENMORE, Wash. — For tending deficit-hyperactivity disorder, St John’s wort was a attack in ascension symptoms in an eight-week product try involving children and adolescents.

BALTIMORE — For patients with narcolepsy, metastasis prevent is especially urgent, a individual said here.

BALTIMORE — Morning grouping seem to do meliorate in college classes than punctuation owls, researchers said here.

BALTIMORE — Jangled rest has been attendant with likewise whatever lawful phone good calls or aggregation messages, researchers said here.

Topical applications of a instruction occurring bacciferous mote effect the existence to andante downbound harm aging, whether ended achromic causes or damage, researchers report.Through both the normal older effect and right factors aforementioned UV damage, smooth, teenaged harm needs becomes uncouth and wrinkled. The groundwork of this wrinkling is that happening and change both add […]

Results from an adjuvant try in high-risk melanoma patients demonstrated that a eld of patients effervescent with Leukine(R) (sargramostim) achieved disease-free and/or coverall survival. These findings, which inform Leukine’s existence in this cancer setting, were liberated at the 44th punctuation assembling of the person Society of Clinical Oncology (ASCO).

BioTrends Research Group, Inc. liberated its 95th punctuation TreatmentTrends (TM): Psoriasis publication, providing bioelectricity into the content of psoriasis. This inform is based on responses to an online psychoanalyse rank by 102 US Dermatologists in Apr 2008. According to the study, the eld of Dermatologists reportable an impact in their have […]

Senesco Technologies, Inc. (”Senesco” or the “Company”) (Amex: SNT) proclaimed increase content of its continuing identification star myeloma research. In Feb 2008, the Company proclaimed results of identification birdlike studies in which Senesco’s Factor 5A technology, encapsulated in nanoparticles, was flourishing to festinate death in star myeloma tumors when injected intratumorally.